These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1056276)

  • 1. Polycythemia vera treated with -32p and myleran: development of chronic granulocytic leukemia with chromosomal abnormalities in one patient.
    Staven P; VAN DER Hagen CB; Vogt E; Sandnes K
    Clin Genet; 1975 Mar; 7(3):227-31. PubMed ID: 1056276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P.
    Krańik W
    Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Busulfan versus 32P in polycythaemia vera.
    Zittoun R
    Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
    Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of Polycythemia vera and thrombocythemia with myleran (busulphan).
    Epstein IS
    Isr J Med Sci; 1965 Jul; 1(4):797-9. PubMed ID: 5892718
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmune hemolytic anemia in chronic granulocytic leukemia.
    Maldonado NI; Haddock J; Pérez-Santiago E
    Blood; 1967 Oct; 30(4):518-21. PubMed ID: 5233978
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment by radiophosphorus versus busulfan in polycythemia vera: a randomized trial (E.O.R.T.C.'s) "leukemias and hematosarcomas" group.
    Recent Results Cancer Res; 1977; (62):104-9. PubMed ID: 341245
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival of patients with polycythemia vera on busulfan or 32P.
    Mathé G
    N Engl J Med; 1978 Feb; 298(5):279. PubMed ID: 619270
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transition of polycythemia vera into acute or chronic granulocytic leukemia in the course of treatment with radioactive P-32].
    Kraśnik W
    Pol Tyg Lek; 1975 Feb; 30(6):233-6. PubMed ID: 1054155
    [No Abstract]   [Full Text] [Related]  

  • 10. Patho-anatomical features of the bone marrow.
    Lennert K; Nagai K; Schwarze EW
    Clin Haematol; 1975 Jun; 4(2):331-51. PubMed ID: 1102191
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. "Leukemia and Hematosarcoma" Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.).
    Br J Cancer; 1981 Jul; 44(1):75-80. PubMed ID: 7020738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of busulfan (myleran) therapy of polycythemia vera].
    Urasiński I; Mysik M
    Pol Arch Med Wewn; 1969 Apr; 42(4):661-7. PubMed ID: 5792045
    [No Abstract]   [Full Text] [Related]  

  • 13. Polycythemia rubra vera progressing to Ph1-positive chronic myelogenous leukemia.
    Hoppin EC; Lewis JP
    Ann Intern Med; 1975 Dec; 83(6):820-3. PubMed ID: 1060394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation t(3;21)(q26;q22) in acute myeloblastic leukemia secondary to polycythemia vera.
    Dastugue N; Pris J; Colombies P
    Cancer Genet Cytogenet; 1990 Feb; 44(2):275-6. PubMed ID: 2297687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune hemolytic anemia 7 years after polycythemia vera].
    Raya Muńoz J; Diez Ruiz A; Soto Mas J; Perez Galvez M; Caffarena Gonzalez C; Peña Yañez A
    Rev Clin Esp; 1983 Feb; 168(4):289-91. PubMed ID: 6856919
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of polycythemia vera treated with myleran].
    Migdal A
    Wiad Lek; 1966 May; 19(9):737-9. PubMed ID: 5963614
    [No Abstract]   [Full Text] [Related]  

  • 17. Busulphan: effect on platelet RNA dependent DNA polymerase--implications in the treatment of polycythemia vera, thrombosis and atherosclerosis.
    Brodsky I
    Biomed Pharmacother; 1982; 36(3):125-7. PubMed ID: 6185158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
    Parmentier C; Gardet P
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic granulocytic leukaemia.
    Baikie AG
    Med J Aust; 1974 Jul; 2(1):12-7. PubMed ID: 4528473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.